Get the Stockscreener App
1.61
1.83%
-0.03
After Hours:
1.66
0.05
+3.11%
Taysha Gene Therapies Inc Stock (TSHA) Latest News
Taysha Gene Therapies (TSHA) Projected to Post Earnings on Wednesday - Defense World
Taysha Gene Therapies to Release Full-Year 2024 Financial - GlobeNewswire
Taysha Gene Therapies to Release Full-Year 2024 Financial Results and Host Conference Call and Webcast on February 26 - The Manila Times
Gene Therapy Pioneer Taysha Readies Crucial 2024 Financial DisclosureHere's When - StockTitan
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Brokerages - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by SG Americas Securities LLC - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 1.3%Time to Buy? - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Critical Analysis: Creative Medical Technology (NASDAQ:CELZ) vs. Taysha Gene Therapies (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Taysha Gene Therapies Inc (TSHA) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule - TipRanks
Taysha Gene Therapies Inc [TSHA] Records 50-Day SMA of $1.9835 - Knox Daily
Taysha's Strategic Move: 491K Stock Options Awarded to Secure Top Industry Talent - StockTitan
Rett Syndrome Market Growth Projections 2024-2034: - openPR
Prepare Yourself for Liftoff: Taysha Gene Therapies Inc (TSHA) - SETE News
Octagon Capital Advisors LP Increases Stake in Taysha Gene Thera - GuruFocus.com
Scienjoy Holding Leads Our 3 US Penny Stocks To Consider - Simply Wall St
Taysha Gene Therapies Inc (TSHA)’s Market Momentum: Closing Strong at 1.53, Up 2.00 - The Dwinnex
Technical analysis of Taysha Gene Therapies Inc (TSHA) stock chart patterns - US Post News
Taysha Gene Therapies Is Showing Promise For Rett Syndrome - Seeking Alpha
Cantor Fitzgerald Predicts TSHA FY2025 Earnings - Defense World
Brokers Issue Forecasts for TSHA FY2025 Earnings - MarketBeat
Illuminating Rett syndrome: Latest pharmacological advancements - The Pharma Letter
Brokerages Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) PT at $6.63 - MarketBeat
Barclays PLC Increases Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Barclays PLC Boosts Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
JPMorgan Chase & Co. Boosts Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Jane Street Group LLC Sells 20,552 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Principal Financial Group Inc. Sells 5,810 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Given “Buy” Rating at Needham & Company LLC - Defense World
Assessing Taysha Gene Therapies: Insights From 8 Financial Analysts - Benzinga
Taysha Gene Therapies' (TSHA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Acelyrin Leads The Charge With 2 Other US Penny Stocks - Yahoo Finance
Taysha Gene Therapies Grants 311,000 Stock Options to New Employee Under Inducement Plan - StockTitan
100,795 Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Bought by Franklin Resources Inc. - Defense World
Barclays PLC Buys 193,046 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Acquires 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Geode Capital Management LLC Buys 682,273 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Analysts Set Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Price Target at $6.63 - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Short Interest Update - MarketBeat
State Street Corp Has $6.97 Million Stock Holdings in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Wellington Management Group LLP Buys New Shares in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
The Manufacturers Life Insurance Company Sells 72,548 Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - Defense World
Taysha Gene Therapies' SWOT analysis: promising rett syndrome stock faces key tests - Investing.com Canada
Thinking about buying stock in Nikola, Delcath Systems, Taysha G - GuruFocus.com
Fmr LLC Has $37.54 Million Stake in Taysha Gene Therapies, Inc. (NASDAQ:TSHA) - MarketBeat
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Shares Sold by Fmr LLC - Defense World
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 6.3%Still a Buy? - MarketBeat
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):